Collateral Growth: Cells Arrive at the Construction Site

Vascular

Volumn 10, Issue 6, 2002, Pages 570-578

  Heilmann, Claudia ^a   Beyersdorf, Friedhelm ^a   Lutter, Georg ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BLOOD; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; COLLATERAL CIRCULATION; DEVELOPMENT; ENDOTHELIUM CELL; HEART MUSCLE; ISCHEMIA; MACROPHAGE; MIGRATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; STEM CELL; VESSEL;

ARTERIAL OCCLUSIVE DISEASES; COLLATERAL CIRCULATION; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; MACROPHAGES; MONOCYTES; TRANSCRIPTION FACTORS;

EID: 0036890667     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721090201000610     Document Type: Article

References (74)

1. Gale, N. W. and Yancopoulos, G. D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev, 1999, 13, 1055-1066.
2. Schaper, W. Coronary collateral development: concepts and hypotheses. In Collateral circulation, eds Schaper, W. and Schaper, J. Kluwer Academic Publishers, Dortrecht, Norwell 1993, pp. 41-64.
3. Torres Filho, I. P. Kerger, H. and Intaglietta, M. pO2 measurements in arteriolar networks. Microvasc Res, 1996, 51, 202-212.
4. van Royen, N. Pick, J. J. Buschmann, I. et al. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res, 2001, 49, 543-553.
5. Folkman, J. Therapeutic angiogenesis in ischemic limbs. Circulation, 1998, 97, 1108-1110.
6. Risau, W. Mechanisms of angiogenesis. Nature, 1997, 386, 671-674.
7. Schaper, W. and Buschmann, I. Arteriogenesis, the good and bad of it. Cardiovasc Res, 1999, 43, 835-837.
8. Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nat Med, 2000, 6, 389-395.
9. Moldovan, N. I. Goldschmidt-Clermont, P. J. Parker-Thornburg, J. et al. Contribution of monocytes/macrophages to compensatory neovascularization. Circ Res, 2000, 87, 378-384.
10. Xie, Z. Gao, M. Batra, S. et al. The capillarity of left ventricular tissue of rats subjected to coronary artery occlusion. Cardiovasc Res, 1997, 33, 671-676.
11. Lyn, D. Liu, X. Bennett, N. A. et al. Gene expression profile in mouse myocardium after ischemia. Physiol Genomics, 2000, 2, 93-100.
12. Zimmermann, R. Arras, M. Ullmann, C. et al. Time course of mitosis and collateral growth following coronary microembolization in the porcine heart. Cell Tissue Res, 1997, 287, 583-590.
13. Arras, M. Strasser, R. Mohri, M. et al. Tumor necrosis factoralpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Baste Res Cardiol, 1998, 93, 97-107.
14. Couffinhal, T. Silver, M. Zheng, L. P. et al. Mouse model of angiogenesis. Am J Pathol, 1998, 152, 1667-1679.
15. Scholz, D. Ito, W. Fleming, I. et al. Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch, 2000, 436, 257-270.
16. Lee, S. H. Wolf, P. L. Escudero, R. et al. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med, 2000, 342, 626-633.
17. Xu, X. Li, J. Simons, M. et al. Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial ischemia. J Thorac Cardiovasc Surg, 2001, 121, 735-742.
18. Kranz, A. Rau, C. Kochs, M. et al. Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance. J Mol Cell Cardiol, 2000, 32, 65-72.
19. Khachigian, L. M. and Collins, T. Inducible expression of Egr- 1-dependent genes. Circ Res, 1997, 81, 457-461.
20. Silverman, E. S. and Collins, T. Pathways of Egr-1-mediated gene transcription in vascular biology. Am J Pathol, 1999, 154, 665-670.
21. Yan, S. F. Fujita, T. Lu, J. et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nature Med, 2000, 6, 1355-1361.
22. Honkaniemi, J. States, B. A. Weinstein, P. R. et al. Expression of zinc finger immediate early genes in rat brain after permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab, 1997, 17, 636-646.
23. Honkaniemi, J. and Sharp, F. R. Global ischemia induces immediate-early genes encoding zinc finger transcription factors. J Cereb Blood Flow Metab, 1996, 16, 557-565.
24. Beckmann, A. M. and Wilce, P. A. Egr transcription factors in the nervous system. Neurochem Int, 1997, 31, 477-510.
25. Huang, L. E. Gu, J. Schau, M. et al. Regulation of hypoxia-inducible factor I alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA, 1998, 95, 7987-7992.
26. Semenza, G. L. Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor-1. J Clin Invest, 2000, 106, 809-812.
27. Stein, I. Neeman, M. Shweiki, D. et al. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol, 1995, 15, 5363-5368.
28. Ferrara, N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol, 2001, 280, 1358-1366.
29. Zachary, I. and Gliki, G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res, 2001, 49, 568-581.
30. Halayko, A. J. and Solway, J. Molecular mechanisms of phenotypic plasticity in smooth muscle cells. J Appl Physiol, 2001, 90, 358-368.
31. Deroanne, C. F. Lapiere, C. M. and Nusgens, B. V. In vitro tubulogenesis of endothelial cells by relaxation of the coupling extracellular matrix-cytoskeleton. Cardiovasc Res, 2001, 49, 647-658.
32. Quaranta, V. Cell migration through extracellular matrix: membrane-type metalloproteinases make the way. J Cell Biol, 2000, 149, 1167-1170.
33. Nagase, H. and Woessner, J. F. Matrix metalloproteinases. J Biol Chem, 1999, 274, 21491-21494.
34. Hotary, K. Allen, E. Punturieri, A. et al. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol, 2000, 149, 1223-1309.
35. Hershey, J. C. Baskin, E. P. Glass, J. D. et al. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res, 2001, 49, 618-625.
36. Rivard, A. Fabre, J. E. Silver, M. et al. Age-dependent impairment of angiogenesis. Circulation, 1999, 99, 111-120.
37. Couffinhal, T. Silver, M. Kearney, M. et al. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/-mice. Circulation, 1999, 99, 3188-3198.
38. Waltenberger, J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res, 2001, 49 (3), 554-560.
39. Goede, V. Brogelli, L. Ziche, M. et al. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer, 1999, 82, 765-770.
40. Marumo, T. Schini-Kerth, V. B. and Busse, R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes, 1999, 48, 1131-1137.
41. Wempe, F. Lindner, V. and Augustin, H. G. Basic fibroblast growth factor (bFGF) regulates the expression of the CC chemokine monocyte chemoattractant protein-1 in autocrine-activated endothelial cells. Arterioscler Thromb Vasc Biol, 1997, 17, 2471-2478.
42. Shyy, Y. J. Hsieh, H. J. Usami, S. et al. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc Natl Acad Sci USA, 1994, 4678-1682.
43. Bao, X. Lu, C. and Frangos, J. A. Temporal gradient in shear but not steady shear stress induces PDGF-A and MCP-1 expression in endothelial cells: role of NO, NF kappa B, and egr- 1. Arterioscler Thromb Vasc Biol, 1999, 19, 996-1003.
44. Behr, T. M. Wang, X. Aiyar, N. et al. Moncyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure. Circulation, 2000, 102, 1315-1322.
45. Fuchs, S. Baffour, R. and Zhou, Y. F. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol, 2001, 37, 1726-1732.
46. Yoshimura, T. Yuhki, N. Moore, S. K. et al. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett, 1989, 244, 487-493.
47. Denger, S. Jahn, L. Wende, P. et al. Expression of moncyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis. Atherosclerosis, 1999, 144, 15-23.
48. Ito, W. D. Arras, M. Winkler, B. et al. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res, 1997, 80, 829-837.
49. Hoefer, I. E. van Royen, N. Buschmann, I. R. et al. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res, 2001, 49, 609-617.
50. Asahara, T. Masuda, H. Takahashi, T. et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res, 1999, 85, 221-228.
51. Shi, Q. Rafii, S. Wu, M. H. et al. Evidence for circulating bone marrow-derived endothelial cells. Blood, 1998, 92, 362-367.
52. Peichev, M. Naiyer, A. J. Pereira, D. et al. Expression of VEGFR-2 and AC 133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood, 2000, 95, 952-958.
53. Gehling, U. M. Ergun, S. Schumacher, U. et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood, 2000, 95, 3106-3112.
54. Sato, T. Laver, J. H. and Ogawa, M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood, 1999, 94, 2548-2554.
55. Goodell, M. A. CD34+ or CD34-: Does it really matter? Blood, 1999, 94, 2545-2547.
56. Miraglia, S. Godfrey, W. Yin, A. H. et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood, 1997, 90, 5013-5021.
57. Yin, A. H. Miraglia, S. Zanjani, E. D. et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 1997, 90, 5002-5012.
58. Corbeil, D. Roper, K. Hellwig, A. et al. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem, 2000, 275, 5512-5520.
59. Ziegler, B. L. Valtieri, M. Porada, G. A. et al. KDR receptor: a key marker defining hematopoietic stem cells. Science, 1999, 285, 1553-1558.
60. Yamashita, J. Itoh, H. Hirashima, M. et al. Flk-1-positive cells derived from embryonic stem cells serve as vascular progenitor cells. Nature, 2000, 408, 92-96.
61. Kalka, C. Masuda, H. Takahashi, T. et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Set USA, 2000, 97, 3422-3427.
62. Shintani, S. Murohara, T. Ikeda, H. et al. Augmentation of postnatal neovascularization with autologous bone narrow transplantation. Circulation, 2001, 103, 897-903.
63. Takahashi, T. Kalka, C. Masuda, H. et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med, 1999, 5, 434-438.
64. Asahara, T. Takahashi, T. Masuda, H. et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J, 1999, 18, 3964-3972.
65. Kalka, C. Masuda, H. Takahashi, T. et al. Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res, 2000, 86, 1198-1202.
66. Kalka, C. Tehrani, H. and Laudenberg, B. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann Thorac Surg, 2000, 70, 829-834.
67. Hattori, K. Oias, S. Heissig, B. et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med, 2001 M7, 193 (9), 1005-1014.
68. Asahara, T. Murohara, T. Sullivan, A. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275, 964-967.
69. Shintani, S. Murohara, T, Ikeda, H. et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 2001, 103, 2776-2779.
70. Kobayashi, T. Hamano, K. Li, T. S. et al. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res, 2000, 89, 189-195.
71. Gomez-Navarro, J. Contreras, J. L. Arafat, W. et al. Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model. Gene Ther, 2000, 7, 43-52.
72. Ikenaga, S. Hamano, K. Nishida, M. et al. Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model. J Surg Res, 2001, 96, 277-283.
73. Orlic, D. Kajstura, J. Chimenti, S. et al. Bone marrow cells regenerate infarcted myocardium. Nature, 2001, 410, 701-705.
74. Kawamoto, A. Gwon, H. C. Iwaguro, H. et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation, 2001, 103, 634-637.